CDC clears COVID booster shots for seniors, at-risk, and — siding with FDA over advisory panel — frontline workers
The Centers for Disease Control and Prevention late Thursday gave final authorization for tens of millions of Americans to get a COVID-19 booster shot — but it sided with the Food and Drug Administration over its own advisory panel in approving a third dose of the Pfizer-BioNTech vaccine for people 18 and older who are at greater risk of infection because of their jobs. The other groups that can now sign up for booster shots are people 65 and older, those living in long-term care facilities, and adults 50 and older who have underlying health conditions.
CDC Director Rochelle Walensky suggested Thursday night that she overruled the Advisory Committee on Immunization Practices regarding frontline workers because it's her job "to recognize where our actions can have the greatest impact," and based on the "complex, often imperfect data," the CDC "must take actions that we anticipate will do the greatest good." The authorization only applies to a third Pfizer shot at least six months after a person's second dose, but Walensky said the CDC "will address, with the same sense of urgency, recommendations for the Moderna and J & J vaccines as soon as those data are available."
The CDC immunization advisory panel had agreed with the FDA on most booster populations it authorized Wednesday night, but it voted 9 to 6 against recommending third shots for health-care providers, teachers, prison guards, grocery store workers, and others whose "frequent institutional or occupational exposure" puts them at greater risk.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Some panel members said they voted against boosters for frontline workers because it opened the door to too many people or gave the false impression that the vaccines aren't still incredibly effective at protecting most people against serious illness, hospitalization, and death. Others suggested boosters might take focus off the primary goal of getting unvaccinated people their first shots.
Biden administration officials had quietly hoped the CDC would side with the FDA, both so the nation's two top public health agencies would be in accord and also because President Biden and his advisers had wanted the booster shots cleared for most vaccinated Americans. In any case, "in reality, anyone who wants a booster will get one, as has already been happening," a federal health official told The Washington Post. More than two-thirds of COVID vaccinations are administered at pharmacies, and people don't need prescriptions or other documentation to get jabbed.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Was the Azerbaijan Airlines plane shot down?
Today's Big Question Multiple sources claim Russian anti-aircraft missile damaged passenger jet, leading to Christmas Day crash that killed at least 38
By Harriet Marsden, The Week UK Published
-
Ukraine hints at end to 'hot war' with Russia in 2025
Talking Points Could the new year see an end to the worst European violence of the 21st Century?
By Rafi Schwartz, The Week US Published
-
What does the FDIC do?
In the Spotlight Deposit insurance builds confidence in the banking system
By Joel Mathis, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published